BDMD Stock Overview
Betters Medical Investment Holdings Limited, along with its subsidiaries manufactures microwave ablation and other medical devices for minimally invasive tumor treatment.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Baird Medical Investment Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$4.32 |
| 52 Week High | US$13.52 |
| 52 Week Low | US$4.68 |
| Beta | 0 |
| 11 Month Change | -60.66% |
| 3 Month Change | -60.91% |
| 1 Year Change | -59.36% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -55.33% |
Recent News & Updates
Recent updates
Shareholder Returns
| BDMD | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -60.8% | -2.5% | -0.7% |
| 1Y | -59.4% | 19.8% | 32.5% |
Return vs Industry: BDMD underperformed the US Medical Equipment industry which returned 19.8% over the past year.
Return vs Market: BDMD underperformed the US Market which returned 32.5% over the past year.
Price Volatility
| BDMD volatility | |
|---|---|
| BDMD Average Weekly Movement | 17.2% |
| Medical Equipment Industry Average Movement | 8.5% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: BDMD's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: BDMD's weekly volatility has increased from 9% to 17% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | n/a | Haimei Wu | www.baidesz.com |
Betters Medical Investment Holdings Limited, along with its subsidiaries manufactures microwave ablation and other medical devices for minimally invasive tumor treatment. The company was founded in 2012 and is headquartered in Guangzhou, China.
Baird Medical Investment Holdings Limited Fundamentals Summary
| BDMD fundamental statistics | |
|---|---|
| Market cap | US$8.00b |
| Earnings (TTM) | US$10.54m |
| Revenue (TTM) | US$26.79m |
0.0x
P/E Ratio0.0x
P/S RatioIs BDMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BDMD income statement (TTM) | |
|---|---|
| Revenue | CN¥188.66m |
| Cost of Revenue | CN¥31.92m |
| Gross Profit | CN¥156.74m |
| Other Expenses | CN¥82.54m |
| Earnings | CN¥74.21m |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did BDMD perform over the long term?
See historical performance and comparison